Psychedelic therapy Psychedelic therapy Psychedelic therapy refers to therapeutic practices involving psychedelic drugs, oftentimes utilizing serotonergic psychedelics such as LSD, psilocybin, DMT, MDMA, mescaline, and 2C-B. Psychedelic therapy, in contrast to conventional psychiatric medication taken by the patient regularly or as-needed, patients generally remain in an extended psychotherapy session during the acute psychedelic activity with additional sessions both before and after in order to help integrate experiences with the drug. Psychedelic therapy, in the broadest possible sense of the term, may have originated from prehistoric knowledge of hallucinogenic plants. They grow naturally in certain cacti, seeds, bark and roots of various plants.
Sodium fluoroacetate brand name. The salt is synthesized by treating sodium chloroacetate with potassium fluoride. Potassium fluoroacetate (as opposed to the commercially manufactured sodium salt) occurs naturally in at least 40 plant species in Australia, Brazil, and Africa. It was first identified in "Dichapetalum cymosum", commonly known as gifblaar (Afrikaans) or poison leaf, by Marais in 1944. As early as 1904, colonists in Sierra Leone used extracts of "Chailletia toxicaria", which also contains fluoroacetic acid or its salts, to poison rats. Several native Australian plant genera contain the toxin, including "Gastrolobium", "Gompholobium", "Oxylobium", "Nemcia", and "Acacia". "Gastrolobium" is a genus of flowering